New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment Sarah Zimner-RapuchNicolas JanusVincent Launay-Vacher Leading Article 25 July 2014 Pages: 1307 - 1313
Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections J. Alexander ViehmanM. Hong NguyenYohei Doi Therapy in Practice 05 August 2014 Pages: 1315 - 1333
Functional Esophageal Disorders: Pharmacological Options Gehanjali AmarasingheDaniel Sifrim Therapy in Practice 08 August 2014 Pages: 1335 - 1344
Asthma Therapy and Its Effect on Airway Remodelling Rachid BerairChristopher E. Brightling Review Article 24 July 2014 Pages: 1345 - 1369
Tafamidis: A Review of Its Use in Familial Amyloid Polyneuropathy Lesley J. Scott Adis Drug Evaluation 15 July 2014 Pages: 1371 - 1378
Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases Lesley J. Scott Adis Drug Evaluation 18 July 2014 Pages: 1379 - 1410
Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis Mark Sanford Adis Drug Evaluation 26 July 2014 Pages: 1411 - 1433
Cabozantinib: A Review of Its Use in Patients with Medullary Thyroid Cancer Sheridan M. Hoy Adis Drug Evaluation 24 July 2014 Pages: 1435 - 1444
Nemonoxacin: First Global Approval Raewyn M. Poole R&D Insight Report 31 July 2014 Pages: 1445 - 1453
Erratum to: Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor Henri BounameauxA. John Camm Erratum 20 August 2014 Pages: 1455 - 1455
